Ye Weiguo 4

What Happened

• Ye Weiguo, Chief Operating Officer of Gyre Therapeutics (GYRE), exercised a total of 11,000 options (vested in full) and sold the 11,000 resulting shares in open-market transactions between June 9 and June 18, 2026.
• Exercise details: 3,000 shares on 6/9, 5,000 on 6/10, and 3,000 on 6/18 at an exercise price of $0.75 per share (total cash paid ≈ $8,250). Sale details: the corresponding sales generated about $68,700 total (3,000 @ $6.15 on 6/9 = $18,450; 5,000 @ $6.24 on 6/10 = $31,200; 3,000 @ $6.35 on 6/18 = $19,050).
• These transactions are primarily sales of shares that resulted from option exercises (i.e., the insider exercised options and sold the shares). Such sell transactions are often routine (e.g., to cover exercise costs or diversify) but do not by themselves indicate company outlook.

Key Details

• Dates and prices:
  • 2026-06-09: exercised 3,000 @ $0.75; sold 3,000 @ $6.15 (≈ $18,450)
  • 2026-06-10: exercised 5,000 @ $0.75; sold 5,000 @ $6.24 (≈ $31,200)
  • 2026-06-18: exercised 3,000 @ $0.75; sold 3,000 @ $6.35 (≈ $19,050)
• Totals: 11,000 options exercised; 11,000 shares sold; sale proceeds ≈ $68,700; exercise cost ≈ $8,250.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes: F1 — reported sale price is a weighted average; underlying trades were made at multiple prices (the filing notes sales in the $6.20–$6.30 range and says breakdowns can be provided on request). F2 — the options were fully vested.
• Timeliness: Form filed 2026-06-22 for transactions occurring 2026-06-09 through 2026-06-18. Form 4 is generally required within two business days of a reportable transaction, so this filing was submitted later than that window.

Context

• These entries are coded as M (option exercise) and S (open-market sale). The filing shows the exercises and contemporaneous sales of the exercised shares — effectively an exercise followed by immediate/near-immediate sale.
• For retail investors: exercises followed by sales are common and often reflect liquidity or standard option-exercise behavior rather than a signal about company fundamentals. No 10% owner, gift, or award activity is indicated in these transactions.